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OBJECTIVES We tested the hypothesis that one health status measure, the Kansas City Cardiomyopathy
Questionnaire (KCCQ), provides prognostic information independent of other clinical data
in outpatients with heart failure (HF).
BACKGROUND Health status measures are used to describe a patient’s clinical condition and have been shown
to predict mortality in some populations. Their prognostic value may be particularly useful
among patients with HF for identifying candidates for disease management in whom
increased care may reduce hospitalizations and prevent death.
METHODS We evaluated 505 HF patients from 13 outpatient clinics who had an ejection fraction40%
using the KCCQ summary score. Proportional hazards regression was used to evaluate the
association between the KCCQ summary score (range, 0 to 100; higher scores indicate better
health status) and the primary outcome of death or HF admission, adjusting for baseline
patient characteristics, 6-min walk distance, and B-type natriuretic peptide (BNP).
RESULTS The mean age was 61 years, 76% of patients were male, 51% had an ischemic HF etiology,
and 5% were New York Heart Association functional class IV. At 12 months, among the 9%
of patients with a KCCQ score 25, 37% had been admitted for HF and 20% had died,
compared with 7% (HF admissions) and 5% (death) of those with a KCCQ score 75 (33%
of patients, p  0.0001 for both comparisons). In sequential multivariable models adjusting
for clinical variables, 6-min walk, and BNP levels, the KCCQ score remained significantly
associated with survival free of HF hospitalization.
CONCLUSIONS A low KCCQ score is an independent predictor of poor prognosis in outpatients with
HF. (J Am Coll Cardiol 2006;47:752–6) © 2006 by the American College of Cardiology
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.021Foundation
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providers routinely rely on crude surrogates for health
tatus, particularly the New York Heart Association (NYHA)
lass, in their management of patients with heart failure (HF).
he assessment, however, is generally subjective and poorly
tandardized, and is based on the clinician’s opinion of the
elative importance of different symptoms on patients’ func-
ion. Recently, efforts have been made to standardize the
valuation of health status from the patient’s perspective,
oth for use as an outcome in clinical trials and as an aid for
linical management. One such instrument, The Kansas
ity Cardiomyopathy Questionnaire (KCCQ), is a HF-
pecific measure of health status and quality of life (1). It has
een proven to be reliable and highly responsive to clinical
hanges deemed important by cardiologists (1).
From the *VA Palo Alto Health Care System, Palo Alto, California; the †Mid
merica Heart Institute of Saint Luke’s Hospital, Kansas City, Missouri; ‡Emory
niversity, Atlanta, Georgia; §Denver VA Medical Center, Denver, Colorado; Yale
niversity, New Haven, Connecticut; ¶Duke University Medical Center, Durham,
orth Carolina; #Denver Health Medical Center, Denver, Colorado; and **North-
estern University, Evanston, Illinois. Project support was from an unrestricted grant
y Pharmacia, Inc. Biosite, Inc., donated supplies to measure B-type natriuretic
eptide. Drs. Rumsfeld and Heidenreich were supported by VA Health Services
esearch Career Development Awards. Saif Rathore was supported by NIH/National
nstitute of General Medical Sciences Medical Scientist Training Grant GM07205.e
Manuscript received July 26, 2005; revised manuscript received August 23, 2005,
ccepted September 26, 2005.Health status measures may be important in the clinical
are of patients with cardiovascular disease not only because
hey are responsive to an increasing emphasis on patient-
entered outcome measures, but also because they may be
ndependently predictive of morbidity and mortality. In this
tudy, we sought to determine whether the KCCQ is
ssociated with survival and future hospitalization for out-
atients with HF.
ETHODS
tudy population. Patients were recruited through the
ardiovascular Outcomes Research Consortium. A list of
articipating investigators and institutions is provided in the
ppendix. A total of 547 outpatients were enrolled at 13
orth American centers, with a range of 3 to 82 (median,
3) patients per site. Eligibility criteria included patients’
wareness of their HF diagnosis, an ejection fraction40%,
ge 30 years, a willingness to provide informed consent,
nd either a HF diagnosis in their outpatient medical record
r a hospitalization for decompensated HF within the
revious three years. Institutional review board approval at
ach site was secured before study implementation.
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February 21, 2006:752–6 Health Status Predicts Prognosis in HFealth status questionnaire. The KCCQ is a 23-item,
elf-administered questionnaire that quantifies physical
unction, symptoms, social function, self-efficacy, and qual-
ty of life for patients with HF. The validity and reliability
nd responsiveness to clinical change of this questionnaire
ave been previously established (1). The KCCQ summary
core integrates information from the physical limitation,
ymptom, social limitation, and quality of life scales and was
sed for all analyses. The range for this scale is 0 to 100;
Table 1. Patient Characteristics
Kansa
<25
n 43
Age (yrs) 59  15
Male 30 (70%)
Caucasian 27 (63%)
NYHA functional class
I 0 (0%)
II 3 (7%)
III 28 (65%)
IV 12 (28%)
Ejection fraction (%) 23  7
Ischemic cause of heart failure 16 (40%)
Hypertension 26 (61%)
Diabetes 18 (42%)
Pulmonary disease 9 (21%)
Atrial fibrillation or flutter 10 (23%)
Prior myocardial infarction 12 (28%)
Renal failure 4 (9%)
Prior stroke 4 (9%)
Medication use
ACE inhibitor 37 (86%)
Angiotensin receptor blocker 4 (9%)
Beta-blocker 30 (70%)
Digoxin 30 (70%)
Spironolactone 15 (35%)
Diuretic 40 (93%)
Calcium antagonist 5 (12%)
Physical examination
Systolic blood pressure (mm Hg) 111  28
Diastolic blood pressure (mm Hg) 69  18
Pulse 78  17
Jugular venous distension 10 cm 16 (41%)
S3 13 (30%)
Rales 8 (19%)
Body mass index 30  9
Test results
6-min walk test (ft) 590  325
B-type natriuretic peptide (ng/dl) 315  367
Data were missing for B-type natriuretic peptide (177), jugul
Abbreviations and Acronyms
BNP  B-type natriuretic peptide
HF  heart failure
KCCQ  Kansas City Cardiomyopathy Questionnaire
NYHA  New York Heart Association(3), body mass index (3), NYHA functional class (3), race (3), age
ACE  angiotensin-converting enzyme; NYHA  New Yorkigher scores reflect better health status (symptoms, func-
ion, and quality of life).
tudy protocol. A complete history and physical exami-
ation were conducted, and included a NYHA functional
lassification and a 6-min walk test (the distance in
eters walked by a patient indoors on level ground in 6
in) (2). Throughout the initial phase of the study,
oint-of-care instruments capable of measuring B-type
atriuretic peptide (BNP) levels (3) were distributed to
he sites (Biosite Inc., San Diego, California). An ad-
inistrative delay in their distribution resulted in BNP
ssessments being available for 328 (65%) of patients
ith follow-up data. No significant differences in age,
ender, race, HF etiology, or physician’s classification of
hange in HF status were present between those with and
ithout BNP assessments.
Cardiomyopathy Questionnaire
Summary Score
25–49 50–74 >75 p Value
125 172 165
0  14 61  13 63  12 0.40
3 (74%) 129 (75%) 130 (79%) 0.61
4 (67%) 118 (69%) 112 (69%) 0.88
3 (2%) 13 (8%) 40 (24%) 0.001
6 (29%) 81 (47%) 90 (55%) —
9 (63%) 70 (41%) 34 (21%) —
7 (6%) 8 (5%) 0 (0%) —
4  8 25  8 26  8 0.06
1 (49%) 86 (53%) 88 (54%) 0.41
1 (57%) 90 (52%) 99 (60%) 0.51
5 (36%) 58 (34%) 48 (29%) 0.37
9 (23%) 32 (19%) 26 (16%) 0.44
7 (30%) 58 (34%) 50 (30%) 0.59
0 (40%) 76 (44%) 62 (38%) 0.24
7 (6%) 11 (6%) 7 (4%) 0.61
3 (10%) 13 (8%) 14 (9%) 0.86
9 (79%) 141 (82%) 139 (84%) 0.64
3 (18%) 25 (15%) 23 (14%) 0.49
7 (78%) 128 (74%) 128 (78%) 0.67
8 (70%) 102 (59%) 90 (55%) 0.03
5 (44%) 63 (37%) 53 (32%) 0.22
8 (86%) 142 (83%) 125 (76%) 0.02
3 (10%) 11 (6%) 20 (12%) 0.32
6  21 121  25 128  20 0.001
8  15 68  14 71  13 0.26
7  14 72  14 71  14 0.001
8 (17%) 26 (17%) 9 (6%) 0.001
8 (14%) 29 (17%) 19 (12%) 0.024
7 (14%) 19 (11%) 11 (7%) 0.09
0  9 29  7 29  7 0.59
6  328 992  355 1161  363 0.001
9  421 433  400 310  343 0.05
s (61), 6-min walk (32), failure etiology (15), blood pressures City
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Health Status Predicts Prognosis in HF February 21, 2006:752–6utcome. The primary outcome was survival free of HF
ospitalization at one year. Secondary outcomes included
ospitalization for HF and total mortality.
tatistical approach. Baseline characteristics of the study
opulation are presented as frequencies and percentages for
ategorical variables and as mean  SD for continuous
ariables. Differences between patients grouped by KCCQ
core were evaluated using analysis of variance for continu-
us variables and chi-square tests for categorical variables.
ifferences in survival were evaluated with the log-rank test.
roportional hazards analysis was used to compare survival
or patients grouped by KCCQ score while adjusting for
aseline characteristics (age, gender, race, diabetes, hyper-
ension, ejection fraction, ischemic cause of HF, obstructive
ulmonary disease or asthma, atrial fibrillation or flutter,
rior myocardial infarction, renal failure, prior stroke, sys-
olic blood pressure, diastolic blood pressure, pulse, jugular
enous distension, S3, and rales). In multivariable analysis,
NP levels were grouped into quartiles and the KCCQ was
eparated by ranges of 25 points. This latter framework was
dopted to simplify interpretation of KCCQ scores in future
pplications. Statistical analyses were performed using SAS
ersion 8.02 (SAS Institute, Cary, North Carolina).
ESULTS
atient characteristics. A total of 547 outpatients were
nrolled. The mean age of the population was 61 years, 76%
f patients were male, 51% had an ischemic HF etiology,
nd 5% were NYHA functional class IV. Of these, one-year
ollow-up was available in 505 (92%). Those without follow-up
ere not significantly different from those with follow-up
or any of the demographic and clinical variables listed in
able 1.
The summary KCCQ score was below 25 (lowest health
tatus) in 43 (9%) patients, 25 to 49 in 125 (25%) patients,
0 to 74 in 172 (34%) patients, and 75 or more in 165 (33%)
igure 1. The association between the Kansas City Cardiomyopathy
uestionnaire (KCCQ) summary score and New York Heart Associations
NYHA) functional class is shown. Patients with lower scores had a higher
YHA functional class.atients. Baseline demographic, clinical, and health status
haracteristics by KCCQ score group are listed in Table 1.
atients with lower KCCQ scores were more likely to have
higher NYHA functional class (Fig. 1). Lower KCCQ
cores were also associated (p  0.05) with a lower systolic
lood pressure, a higher pulse rate, greater jugular venous
istension, a shorter 6-min walk distance, and treatment
ith diuretics and digoxin. Trends (p  0.10) were
bserved for a higher prevalence of rales, a lower ejection
raction, and a higher BNP level in those with lower KCCQ
cores.
F hospitalizations and survival. There were 124
24.6%) patients that either died (n  56) or were hospi-
alized for HF during the one-year follow-up period.
atients with lower KCCQ scores had more hospitaliza-
ions for HF than those with higher scores (Fig. 2). When
ompared with those with a KCCQ score of 75 or greater,
hose with a score 25 were five times as likely to be
ospitalized for HF during the next year (37% vs. 7%).
Mortality increased with decreasing KCCQ score (Fig. 3).
ne-year mortality was four-fold greater in those with a
CCQ score 25 compared with those with a score of 75
r greater (20% vs. 5%). The relationship between KCCQ
core group and the primary outcome, survival free of
ospitalization for HF, is shown in Figure 4. Differences in
urvival free from HF hospitalization between high and low
CCQ score groups were noted by one month and contin-
ed to widen over time. At one year, 45% of patients with
CCQ scores 25 had died or been hospitalized for HF
ompared with 12% for those with KCCQ scores of 75 or
reater.
In multivariable proportional hazards analysis, the
CCQ score remained predictive of survival free from HF
ospitalization after adjustment for clinical characteristics
Table 2). Although adjustment for BNP levels reduced the
ample size by 44%, both BNP (p  0.005) and KCCQ
core (p  0.007) were independently associated with
igure 2. One-year hospitalization for heart failure (HF) is shown for
atients grouped by Kansas City Cardiomyopathy Questionnaire (KCCQ)
ummary score. Those with the lowest scores had the highest rate of heart
ailure admission.urvival free from HF hospitalization.
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February 21, 2006:752–6 Health Status Predicts Prognosis in HFISCUSSION
eart failure is characterized by both poor survival and
requent hospitalizations, but the course of individual pa-
ients is highly variable (4). Several clinical characteristics
ave been identified that are associated with a poor prog-
osis, including physical examination (S3, elevated jugular
enous pressure) (5), low ejection fraction (6), and labora-
ory findings (e.g., anemia) (7). Health status as estimated
y the physician using the NYHA functional classification
as also been associated with outcome (4,8). In this study
e have shown that poor health status defined by the
atient’s KCCQ responses is also associated with worse
rognosis. In those with a score 25, the rate of HF
ospitalization was five-fold greater and total mortality was
our-fold greater at one year compared with those with
cores of at least 75. These results extend a recently reported
igure 3. All-cause mortality is shown for outpatients with heart failure
rouped by Kansas City Cardiomyopathy Questionnaire (KCCQ) sum-
ary score. Those with the lowest scores had the highest mortality.
igure 4. Survival free from heart failure hospitalization is shown for
utpatients according the baseline Kansas City Cardiomyopathy Question-m
aire (KCCQ) summary score. Patients with the lowest scores had the
orse event-free survival.nalysis of the EPlerenone’s neuroHormonal Efficacy and
Urvival Study (EPHESUS) trial that described an associ-
tion of KCCQ scores with survival and hospitalization by
ncluding patients with a broader range of HF etiologies,
voiding the potential selection biases of a clinical trial, and
y assessing stable outpatients rather than those recently
dmitted with a myocardial infarction (9). All of these
onsiderations increase the generalizability of these findings
nd the potential applicability of the KCCQ in clinical care.
A patient-derived measure that predicts outcome is po-
entially useful for several reasons. First, our study found
hat the summary score from the KCCQ provides additional
nformation to standard demographic, clinical, and labora-
ory data. Specifically, the KCCQ summary score provided
rognostic information independent of these standard char-
cteristics, even when supplemented with six-min walk
istance and BNP level. Thus, including the KCCQ sum-
ary score can improve prognosis estimates for individual
atients. An important advantage of the KCCQ in strati-
ying risk is that it does not require a physical examination,
hlebotomy, or other specialized or invasive training. Thus,
urveying populations of patients to identify those at great-
st risk may be an important method for identifying
igh-risk patients from among a large population of HF
utpatients.
Accordingly, an important potential application of this
nformation is to identify candidates for more intensive
herapy, including cardiology referral and HF programs.
everal trials have found that patients with symptomatic HF
ave reduced hospitalizations and in some cases reduced
able 2. KCCQ Score and Event-Free Survival:
ultivariable Adjustment
Hazard
Ratio
95% Confidence
Interval p Value
odel 1 (no adjustment)
KCCQ score (vs. 75) 0.0001
50–74 2.69 1.25–3.71
25–49 2.72 1.13–3.76
25 5.33 1.32–5.82
odel 2 (adjustment for
clinical variables*)
KCCQ score (vs. 75) 0.003
50–74 2.18 1.23–3.86
25–49 2.32 1.28–4.25
25 3.82 1.87–7.79
odel 3 (clinical variables
and 6-min walk)
KCCQ score (vs. 75) 0.02
50–74 2.15 1.25–3.71
25–49 2.06 1.13–3.76
25 2.77 1.32–5.82
The following clinical variables were tested and included in the model (boldface type)
f they were significantly associated (p  0.05) with event-free survival: age, gender,
ace, diabetes, hypertension, ejection fraction, ischemic cause of heart failure,
bstructive pulmonary disease or asthma, atrial fibrillation or flutter, prior myocar-
ial infarction, renal failure, prior stroke, systolic blood pressure, diastolic blood
ressure, pulse, jugular venous distension, S3, and rales.
KCCQ  Kansas City Cardiomyopathy Questionnaire.ortality when enrolled in programs that use a combination
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Health Status Predicts Prognosis in HF February 21, 2006:752–6f education, home monitoring, and medication manage-
ent (10,11). High-risk patients are the best candidates for
hese programs; however, estimating risk is expensive if it
equires a physician visit or additional laboratory tests.
urrently, administrative data, which suffer from limited
iagnostic accuracy, are all that is available to most health
are organizations. Alternatively, organizations can mail the
CCQ to patients identified from administrative data as
aving HF and identify those with the lowest scores (worse
tatus) to enroll in HF programs or to target for additional
nterventions (e.g., referral to cardiologists).
The KCCQ provides several potential advantages over
he NYHA functional status classification. As previously
oted, the KCCQ is derived from patients, whereas the
YHA class is determined by the clinician. Therefore, the
YHA functional class is by definition subjective and may
nintentionally be influenced by ejection fraction or other
ata available to the physician. The standardized assessment
akes the KCCQ a “more pure” measure of a patient’s
ymptoms and functional status. Finally, the KCCQ in-
ludes the full range of patient health status (symptoms,
unctional status, and health-related quality of life). Health-
elated quality of life is not included in NYHA functional
lassification, and yet multiple studies have shown that
ealth-related quality of life is predictive of subsequent
ortality in different cardiac populations (12–14).
Also in keeping with the results of this investigation,
tudies using the Minnesota Living with Heart Failure
uestionnaire have found that survival is greater for patients
ith better health status, independent of ejection fraction
nd NYHA functional class (13,14). Additional studies are
eeded to determine the relative prognostic value of the
CCQ and the Minnesota Questionnaire.
Our study has several potential limitations. Most patients
ere enrolled at outpatient clinics of academic medical
enters, and their mean age is less than that of patients in
he community (4). However, we have no reason to believe
hat the association between health status and outcome is
ifferent at academic and non-academic centers. We in-
luded only patients with systolic dysfunction; thus, it is
nclear whether the KCCQ predicts outcome for patients
ith HF because of isolated diastolic dysfunction or valvular
isease. Finally, additional studies are needed to document
hat using the summary score of the KCCQ results in better
riage and care for HF patients.
In conclusion, this study found that a low KCCQ
ummary score is associated with increased mortality and
ospitalization for HF. This increase in risk with a low
CCQ score was independent of clinical characteristics,
ncluding the 6-min walk distance and the BNP level. The
CCQ is an attractive and inexpensive method of estimat-he health plan interested in identifying high-risk patients
or specific interventions.
eprint requests and correspondence: Dr. Paul A. Heidenreich,
11C Cardiology, Palo Alto VA Health Care System, 3801
iranda Avenue, Palo Alto, California 94304. E-mail: heiden@
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PPENDIX
or a list of the members of the Cardiovascular Outcomes
esearch Consortium, please see the online version of thisng a HF patient’s prognosis for the individual physician or article.
